Abstract
Since the emergence of Novel SARS COV 2 in Wuhan region of china in late 2019, there are various reports of acute kidney injury in patients of COVID 19 disease. The reported incidence of AKI in patients with covid19 varies from 5 - 30% across the globe. Differences may have resulted from definitions of AKI and the populations studied. In this study, we sought to define the rate of AKI among patients hospitalized with COVID-19 and to describe various risk factors and outcomes of AKI in this patient population
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
